|

Home
/ IRDA Update
Insurance cos can repay acquisition costs
after 5 years
The IRDA in its draft accounting norms has said that insurance
companies can amortise acquisition costs for a period of five years.
The deferment of the acquisition of the costs will play an important
role in the balance sheet of a new life insurance company. This
is because first year commission in a life insurance policy can
be as high as 75 percent of the premium. If the companies have to
provide for the entire commission upfront they will have to report
high losses.
The draft norms state that only commission and incentives in the
nature of commission can be deferred when they are expected to give
rise to future premium income. Any other acquisition costs should
be expenses in the year in which they are incurred.
IRDA has also clarified that the capitalised part of the acquisition
cost should be charged to expense in proportion to the premium revenue
recognised unless any other rational or reasonable basis of amortisation
is adopted. The draft report has also prescribed norms for revaluing
investments in shares and property based on market rates with the
surplus to be credited to separate revaluation reserves. Part of
these surpluses can be utilised for declaring bonuses to policyholders
up to the limits prescribed by the IRDA.
Balance sheets of the insurance companies are expected to become
more transparent with a large number of disclosures required to
be made a part of notes to accounts. Insurance companies will also
have to maintain a catastrophe reserve that has to be created out
of the surplus in the policyholder's account.
Accounting norms also state that insurance companies should comply
with the Accounting Standards (AS) issued by the Institute of Chartered
Accountants of India (ICAI) to the extent applicable to Life Insurance
companies except in the case of Accounting Standards - AS 3, AS
13 and AS 17.
AS 13 will not apply as cash flow statements should be prepared
only under the direct method. Also AS 13 will not apply and companies
will have to adopt IRDA guidelines for valuing investments. Moreover,
insurance companies will have to adopt segment reporting irrespective
of whether their securities are listed or not, unlike prescriptions
under AS 17.
More Updates
| Back |
Top | Home
|
|